Legal & General Group Plc Makes New $1.94 Million Investment in Trupanion, Inc. $TRUP

Posted by George Bondi on Sep 7th, 2026

Legal & General Group Plc purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) in the second quarter, HoldingsChannel reports. The institutional investor purchased 78,246 shares of the financial services provider’s stock, valued at approximately $1,938,000.

Several other hedge funds also recently modified their holdings of the company. Kelleher Financial Advisors acquired a new stake in shares of Trupanion in the second quarter valued at $42,000. Parallel Advisors LLC grew its holdings in Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after acquiring an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new position in Trupanion during the fourth quarter worth about $64,000. Quantbot Technologies LP bought a new stake in Trupanion in the second quarter worth about $89,000. Finally, Advisory Services Network LLC bought a new stake in Trupanion in the third quarter worth about $160,000.

Trupanion Stock Performance

Trupanion stock opened at $27.80 on Monday. Trupanion, Inc. has a fifty-two week low of $21.16 and a fifty-two week high of $46.98. The firm’s 50 day simple moving average is $27.44 and its 200-day simple moving average is $25.87. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The company has a market cap of $1.22 billion, a P/E ratio of 52.45, a price-to-earnings-growth ratio of 1.88 and a beta of 1.45.

Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The business had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the prior year, the firm earned $0.22 EPS. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. As a group, equities research analysts predict that Trupanion, Inc. will post 0.63 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on TRUP shares. Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, August 26th. Stifel Nicolaus boosted their target price on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Thursday, August 20th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Atlantic Securities set a $42.00 price target on shares of Trupanion in a research report on Wednesday, July 15th. Finally, Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Trupanion has a consensus rating of “Hold” and a consensus price target of $39.20.

Get Our Latest Stock Report on TRUP

Insider Activity

In related news, COO John R. Gallagher sold 3,604 shares of the stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the sale, the chief operating officer directly owned 33,742 shares of the company’s stock, valued at approximately $1,002,137.40. This represents a 9.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the sale, the chief executive officer owned 175,401 shares of the company’s stock, valued at $5,095,399.05. The trade was a 0.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,046 shares of company stock worth $356,210 over the last quarter. Corporate insiders own 5.58% of the company’s stock.

Trupanion Company Profile

(Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.